These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1454223)

  • 1. Cholinergic fiber loss occurs in the absence of synaptophysin depletion in Alzheimer's disease primary visual cortex.
    Beach TG; McGeer EG
    Neurosci Lett; 1992 Aug; 142(2):253-6. PubMed ID: 1454223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocytochemical distribution of peptidergic and cholinergic fibers in the human amygdala: their depletion in Alzheimer's disease and morphologic alteration in non-demented elderly with numerous senile plaques.
    Benzing WC; Mufson EJ; Armstrong DM
    Brain Res; 1993 Oct; 625(1):125-38. PubMed ID: 8242391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic regional variations in the loss of cortical cholinergic fibers in Alzheimer's disease.
    Geula C; Mesulam MM
    Cereb Cortex; 1996; 6(2):165-77. PubMed ID: 8670647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortical cholinergic fibers in aging and Alzheimer's disease: a morphometric study.
    Geula C; Mesulam MM
    Neuroscience; 1989; 33(3):469-81. PubMed ID: 2636703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive loss of cortical acetylcholinesterase activity in association with cognitive decline in Alzheimer's disease: a positron emission tomography study.
    Shinotoh H; Namba H; Fukushi K; Nagatsuka S; Tanaka N; Aotsuka A; Ota T; Tanada S; Irie T
    Ann Neurol; 2000 Aug; 48(2):194-200. PubMed ID: 10939570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E4 allele dosage does not predict cholinergic activity or synapse loss in Alzheimer's disease.
    Corey-Bloom J; Tiraboschi P; Hansen LA; Alford M; Schoos B; Sabbagh MN; Masliah E; Thal LJ
    Neurology; 2000 Jan; 54(2):403-6. PubMed ID: 10668702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurofibrillary degeneration of cholinergic and noncholinergic neurons of the basal forebrain in Alzheimer's disease.
    Rasool CG; Svendsen CN; Selkoe DJ
    Ann Neurol; 1986 Oct; 20(4):482-8. PubMed ID: 3539000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The decline in synapses and cholinergic activity is asynchronous in Alzheimer's disease.
    Tiraboschi P; Hansen LA; Alford M; Masliah E; Thal LJ; Corey-Bloom J
    Neurology; 2000 Nov; 55(9):1278-83. PubMed ID: 11087768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cholinergic system in aging and neuronal degeneration.
    Schliebs R; Arendt T
    Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Electron-cytochemical study of acetylcholinesterase in the cerebral cortex in Alzheimer's disease].
    Vostrikov VM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(7):1003-6. PubMed ID: 3765981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effects of selective immunolesions of cholinergic neurons of the nucleus basalis magnocellularis on the ascending cholinergic pathways in the rat: a model for Alzheimer's disease.
    Szigeti C; Bencsik N; Simonka AJ; Legradi A; Kasa P; Gulya K
    Brain Res Bull; 2013 May; 94():9-16. PubMed ID: 23357177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do lesions involving the cortical cholinergic pathways help or hinder efficacy of donepezil in patients with Alzheimer's disease?
    Fukui T; Hieda S; Bocti C
    Dement Geriatr Cogn Disord; 2006; 22(5-6):421-31. PubMed ID: 16974095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome oxidase in Alzheimer's disease: biochemical, histochemical, and immunohistochemical analyses of the visual and other systems.
    Wong-Riley M; Antuono P; Ho KC; Egan R; Hevner R; Liebl W; Huang Z; Rachel R; Jones J
    Vision Res; 1997 Dec; 37(24):3593-608. PubMed ID: 9425533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cholinergic treatment depends on cholinergic integrity in early Alzheimer's disease.
    Richter N; Beckers N; Onur OA; Dietlein M; Tittgemeyer M; Kracht L; Neumaier B; Fink GR; Kukolja J
    Brain; 2018 Mar; 141(3):903-915. PubMed ID: 29309600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frontal cortical synaptophysin in Lewy body diseases: relation to Alzheimer's disease and dementia.
    Hansen LA; Daniel SE; Wilcock GK; Love S
    J Neurol Neurosurg Psychiatry; 1998 May; 64(5):653-6. PubMed ID: 9598683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of cholinergic pathways in vascular dementia of the Binswanger type.
    Tomimoto H; Ohtani R; Shibata M; Nakamura N; Ihara M
    Dement Geriatr Cogn Disord; 2005; 19(5-6):282-8. PubMed ID: 15785029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular forms of acetylcholinesterases in Alzheimer's disease.
    Younkin SG; Goodridge B; Katz J; Lockett G; Nafziger D; Usiak MF; Younkin LH
    Fed Proc; 1986 Dec; 45(13):2982-8. PubMed ID: 2430839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: II. Primary and secondary visual cortex.
    Hof PR; Morrison JH
    J Comp Neurol; 1990 Nov; 301(1):55-64. PubMed ID: 1706358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease.
    Masliah E; Mallory M; Alford M; DeTeresa R; Hansen LA; McKeel DW; Morris JC
    Neurology; 2001 Jan; 56(1):127-9. PubMed ID: 11148253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lamina-selective A68 immunoreactivity in primary visual cortex of Alzheimer's disease patients.
    Beach TG; Walker R; McGeer EG
    Brain Res; 1989 Oct; 501(1):171-4. PubMed ID: 2804692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.